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After the introduction of S-methoxypsoralen
into the United States for the treatment of
vitiligo it was observed that albino and normal
patients appeared to have an increased tolerance
of solar exposure following ingestion of the drug.
The testimonial evidence on this point was ex-
tensive and enthusiastic. Preliminary studies
indicated that S-methoxypsoralen taken orally
two or three hours before exposure increased
skin tolerance to ultraviolet radiation and also
promoted melanin pigmentation (1). The im-
pression that S-methoxypsoralen plus graded
exposures to sunlight markedly promoted toler-
ance to ultraviolet light was reported by many
patients and observed by many clinicians. While
it was assumed that this protection was mediated
by an increased melanin deposition in the skin,
the possibility of other more complicated mecha-
nisms has been repeatedly postulated by investi-
gators in the field. Short term trials during 1956
at the Arizona State Prison and the Idaho State
Prison did not produce striking evidence of
altered responses in men receiving 10, 20 and
40 milligrams of 8-methoxypsoralen (2). In the
earlier study in 1955 (1), marked potentiation
of erythema was observed and it was concluded
at that time that S-methoxypsoralen does not
have a specific pigment promoting effect in com-
bination with ultraviolet light, but simply
potentiates all or most of the normal skin re-
sponses to ultraviolet light. Because most of
the testimonial evidence in patients had been
accumulated by prolonged use it was believed
possible that discrepancies between the clinical
impression of benefit and the lack of evidence in
short term but well controlled experiments on
large numbers of men might be explained by
mechanisms which were not active during the
short term trials.
* From the Division of Dermatology, University
of Oregon Medical School, Portland, Oregon.Presented at the Brook Lodge Invitational
Symposium on the Psoralens, sponsored by The
Upjohn Company, Kalamazoo, Michigan, March
27—28, 1958.
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MATERIALs AND METHODS
This experiment was done at the University
of Oregon Medical School in Portland. Eight
young women were exposed to sunlight with
and without oral S-methoxypsoralen. One of
these subjects was Japanese, the others Cau-
casian. On July 5, 1957, subjects R.S. and M.G.
were exposed, subjects A.C. and C.P. on Sep-
tember 4, and subjects B.I., M.Z., L.G. and
J.G. on September 11, 1957. On exposure days
half of the subjects were given capsules contain-
ing 30 mg. of 5-methoxypsoralen and the other
half an equivalent number of identical placebo
capsules. Two hours after ingestion of the cap-
sules, eight of the subjects were exposed in prone
position, two in supine position in direct noon
day sunlight for 30 minutes. For those in prone
position, either the right or left half of the back
was covered and the other half exposed to sun-
light. In those exposed in the supine position,
either the right or the left half of the abdomen
was exposed and the other screened from solar
radiation. Only skin areas that had not been
exposed to sunlight for at least one year were
used in this experiment. On the following day
the subjects were crossed, i.e., those who re-
ceived drug on the first day received placebo on
the second and vice-versa and, of course, the
exposure areas were similarly reversed. The
drugs were administered under a sealed code
so that neither the observers nor the test sub-
jects knew which drug was received. There was
of course, variance among subjects and variability
in the solar intensity, but the crossover design
using each subj ect as his own control eliminated
bias from these factors and also from the possible
factor of pharmacological effects of the S-meth-
oxypsoralen delayed for a period of more than
24 hours. Visual gradings were made of the cry-
thema and pigmentation responses 24 and 48
hours following the exposure. The scale is the
same used in previous studies (1—3). For cry-
thema the units were: 0 = no erythema, 1 + =
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TABLE I
Reflectance as % MgO, one wee/c after solar
exposures
TABLE III
Individual reflectance readings 24 hours after
sunlamp exposure
Red glass filter
Subject
RS
MG
MZ
BI
JG
LG
AC
CP
Red glass filter
8-MOP Placebo ference
52.4 59.0 —6.6
58.6 60.7 —2.1
57.3 60.0 —2.7
51.8 55.9 —4.1
57.6 61.1 —3.5
52.4 57.3 —4.9
61.4 62.8 —1.4
60.0 61.1 —1.1
573 rns filter
8-MOP Placebo Dif-
6 mm. 3 mm. ference
573 millimicron inter-
ference filter
8-MOP 'Placebo ference
22.0 38.5 —16.5
28.7 38.5 —9.8
35.7 41.0 —5.3
27.6 35.0 —7.9
29.4 41.3 —11.9
25.9 35.0 —9.1
39.9 42.0 —2.1
38.5 43.4 —4.9
Subject
RS
MG
AC
CP
LG
JG
BI
MZ
Mean
S.E.
P
50.4
59.7
59.0
58.0
50.4
56.6
52.8
59.0
59.7
62.1
61.4
60.7
58.6
61.4
55.2
61.4
8-MOP
6 mm.
26.2
290
29.0
32.2
25.2
23.1
19.2
31.5
Placebo
3 mm.
35.7
37.4
36.0
36.0
30.8
29.8
23.8
38.5
—9.3
—2.4
—2.4
—2.7
—8.2
—48
—2.4
—2.4
—4.3
<0.01
Mean —3.3 —8.4
S.E.
P <0.01 <0.01
Dif-
erence
—9.5
—8.4
—7.0
—3.8
—5.6
—6.7
—4.6
—7.0
—6.6
<0.01
TABLE II
Reflectances 6 wee/cs after solar exposure
Red glass filter 573 m interference filter
TABLE IV
Mean reflectance s-eadings 24 hours after sunlamp
Dii-Dii- 8-MOP Placebo ferencePlacebo terence8-MOP
51.1
58.6
59.0
56.6
52.4
58.0
52.1
600
Subject
RS
MG
AC
CP
LG
JG
BI
MZ
Mean
SE.
P
60.7
6L4
59.3
59.0
60.4
62.8
57.3
6L8
29.4
37.8
39.9
35.7
28.4
34.0
28.4
34.6
Red filter 573 Filter
8-MOP Placebo 8-MOP Placebo
0mm.
1mm.
2mm.
3mm.
4mm.
6mm.
8mm.
56.0
—
56.4
—
55.9
55.7
55.4
60.3
60.0
59.4
60.1
60.8
—
—
33.5
—
32.7
—
30.1
26.9
25.4
38.2
39.1
36.9
33.5
31.1
—
—
39.9
39.6
38.8
41.0
37.8
42.7
35.4
40.6
—9.6
—2.8
—0.3
—2.4
—8.0
—4.8
—5.2
—1.8
—4.4
<0.01
—10.5
—1.8
+1.1
—5.3
—9.4
—8.7
—7.0
—6.0
—6.0
<0.01
o————o Placebo side
.—. 8-MOP side
barely perceptible, 2+ = pink, 3+ = red,
4+ = fiery red. The pigment scale was: 0 =
no tan, 1+ = barely perceptible, 2 + = light
tan, 3+ = medium tan, 4+ = dark tan. The
amount of erythema in the presence of pigmen-
tation was evaluated by blanching the test
area with thumb traction.
Reflectance readings were taken with the
Photovolt Reflection Meter Model 610-T as
described in another publication (3). The instru-
ment was calibrated against a white standard
referred to magnesium oxide. Readings were
taken with a red filter and with green, blue and
2 4 6 8 0
Minutes exposure
Fia. 1
Oregon 1957
amber tristimulus filters. In addition reflectance
readings were taken through a Baizers inter-
ference filter transmitting in a narrow band with
a peak at 573 millimicrons (5730 A). Following
the sun exposures the subjects were not allowed
to expose the test site to sun or artificial light.
Five or six weeks after the initial experiment the
erythemal response to a mercury source of ultra-
violet light was measured in the test areas.
Small square patches of skin were irradiated by
the General Electric 275 watt reflector sunlamp
(R.S.) at a distance of 15 iaches from the test
area, which produced an intensity of 17 E-vitons
per square centimeter (= 17 Finsens) to the
test site as measured with a General Electric
sunlamp test meter #97. Minimal perceptible
erythema on "average untanned white skin"
is produced by 2500 E-viton seconds pcr cm1 or
2500 Finsen seconds (4). With this intensity of
our source this quantity of erythemal irradia-
tion would be reached in 147 seconds or 2.45
minutes. Patches were exposed to receive one,
two, three and four minutes of exposure on the
placebo side. The methoxsalcn sides were given
two, four, six and eight minutes of exposure to
the ES. sunlamp. The difference in exposure
times was decided upon because the pigmenta-
tion (melanin) was visibly greater on the 8-
mcthoxypsoralcn side in all subjects.
RESULTS
One week following the initial sunlight ex-
posures there was an evident difference between
the sides exposed without and with mcthoxsalcn
(8-MOP). The results are given in Table I.
These reflectance measurements indicate that
both the melanin as sampled by the red filter
and the hemoglobin plus melanin as measured
by the 573 mi interference filter are significantly
greater on the 8-mcthoxypsoralen side than the
placebo side.
The reflectance readings at the time of the
crythema threshold determinations are given
in Table II.
Again the rcflectanccs are lower on the psoralen
sides indicating that greater melanin content
Green
filter
reflectance
difference
from
background
12
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8-MOP
Y =—l563 +l.244X18
6
Placebo
Y1: -l.688+2419X1
4
2
I 2 3 4 5 6 7 8
Minutes of R.S. Sunlamp Exposure at 7 E Vitons/Square cm.
FIG. 2
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573 fitter
reflectance
difference
from
background
12
Minutes of R.S. sunlamp exposure at I? E vitons/square cm.
FIG. 3
had persisted to the time of determination of
the erythema thresholds.
Reflectance values 24 hours after the erythema
producing exposures with the sunlamp are tab-
ulated for the 6-minute exposure windows (102
Finsen minutes) on the methoxsalen side and
three minutes on the placebo side in Table III.
The mean reflectance readings for different
sunlamp exposures are given in Table IV.
It had been found in a previous study (3)
FIG. 4a. The right half of the back was exposed to 30 minutes of sunlight at 12 noon
after taking placebos. The left side received 30 minutes exposure at noon two hours
after taking methoxsalen, 30 mg.
FIG. 4b. Secondary protection of methoxsalen. Five weeks prior to this photo-
graph subject received a 30 minute exposure to noonday sunlight on the left side of her
abdomen two hours after taking methoxsalen, 30 mg. Right side received 30 minutes
of noonday sun after taking placebos. Twenty-four hours prior to this photograph,
17 E-vitons of R.S.G.E. sunlamp exposure was given to the small squares for the
number of minutes indicated. It took twice as much exposure to produce an erythemal
response on the methoxsalen side equivalent to that produced on the placebo side.
Placebo
''2= -3.719 +3.919X2
10
8
6
4
8 MOP
VI = -2.186+l.784X1
0 I 2 3 4 5 6 7 8
Figure 4a
Figure lb
Ic-\_\ )
I-
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TABLE V
Computations for Figs 2 and S
373 Reflectance Green Reflectance
8-MOP Placebo 8-MOP Placebo
Si
1SS
L SE.
5
6.73
5.16
35.47
1.78
2.5
6M8
1.29
39.08
3.92
5
4.66
5.16
16.06
1.24
2.5
4.36
1.29
18.13
2.42
b1 — b1
95% conf —
limits
—2.14
—3.71 to
—0.56
—1.18
—2.28 to
—0.07
that the mean values of erythema ratings made
with the visual grading scale produces an ap-
proximately equal interval scale of reflectance
values. It is, therefore, considered appropriate
(5) to present the arithmetic means of the 1 +,
2+, 3+, and 4 + erythemal ratings. These are
given in Fig. 1.
It was obvious from the examination of the
subjects, from the erythemal gradings, and from
the reflectance data that the side previously
exposed to sunlight with methoxsalen had less
erythemal response to given quantities of ultra-
violet light than the side exposed to sunlight
without the psoralen. For statistical confirma-
tion of this impression the linear regressions of
the green and 573 filter reflectance readings on
exposure time in minutes were computed. The
lines of best fit are given in Figs. 2 and 3. The
difference between the slopes of the two lines
was found to be significantly different at the
5% level for both the 573 reflectance data and
the green reflectance data. The computations
are summarized in Table V.
The difference in response is indicated photo-
graphically in the color plate.
DIscUSSION
The clinical impression that 8-methoxypsoralen
was a primary protectant against ultraviolet
light was not verified by previous carefully con-
trolled tests. The present experiment demon-
strates a marked amount of secondary protection
in skin that had previously been exposed to
sunlight after ingestion of 30 mg. of methoxsalen.
The drug increased the average tolerance of
eight normal subjects by a factor of two when
ultraviolet exposure was given six weeks later.
It is felt that this secondary protection is re-
sponsible for the clinically observed sun pro-
tection in subjects ingesting 8-methoxypsoralen.
It is possible that the protection is due in part
to the increased melanin content of the skin
previously treated with methoxsalen since the
subjects that demonstrated the most protection
had the darkest tan. However, two subjects
who had very minor differences in pigment on
the two test areas still demonstrated the pro-
tection. Thus other factors such as the thick-
ness of the stratum corneum may be involved (6).
SUMMARY
It was demonstrated in eight normal subjects
that a 30 minute exposure to sunlight two hours
after ingesting 30 mg. of methoxsalen will in-
crease the tolerance of the exposed skin to sub-
sequent exposures to ultraviolet light. The
amount of ultraviolet light required to produce
a given erythema response on the skin area
treated five weeks previously with oral 8-meth-
oxypsoralen was nearly twice that required to
produce the same erythema response on the skin
exposed to 30 mm. of sunlight when the sub-
jects had previously received placebo.
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